{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T23:27:55Z","timestamp":1771716475640,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jtct.2024.01.070","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T19:57:45Z","timestamp":1706126265000},"page":"435.e1-435.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with \u03b1\u03b2 T Cell Depletion in a Pediatric Cohort"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6607-1384","authenticated-orcid":false,"given":"Svetlana","family":"Glushkova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa","family":"Shelikhova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7578-9657","authenticated-orcid":false,"given":"Kirill","family":"Voronin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6148-7209","authenticated-orcid":false,"given":"Dmitriy","family":"Pershin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoria","family":"Vedmedskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3513-8299","authenticated-orcid":false,"given":"Yakov","family":"Muzalevskii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexei","family":"Kazachenok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Kurnikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Radygina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ilushina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimma","family":"Khismatullina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexei","family":"Maschan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1735-0093","authenticated-orcid":false,"given":"Michael","family":"Maschan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2024.01.070_bib0001","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MOH.0b013e3283582340","article-title":"Negative depletion of CD3+ and TcR\u03b1\u03b2+ T cells","volume":"19","author":"Handgretinger","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jtct.2024.01.070_bib0002","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.01.070_bib0003","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jtct.2024.01.070_bib0004","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2006-07-038687","article-title":"Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value","volume":"110","author":"Ruggeri","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.01.070_bib0005","first-page":"141","article-title":"Identifying NK alloreactive donors for haploidentical hematopoietic stem cell transplantation","volume":"1393","author":"Ruggeri","year":"2016"},{"key":"10.1016\/j.jtct.2024.01.070_bib0006","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4049\/jimmunol.172.1.644","article-title":"Determinants of antileukemia effects of allogeneic NK cells","volume":"172","author":"Leung","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2024.01.070_bib0007","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2141.2007.06631.x","article-title":"Intensity of HLA class I expression and KIR-mismatch determine NK-cell mediated lysis of leukaemic blasts from children with acute lymphatic leukaemia","volume":"138","author":"Pfeiffer","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2024.01.070_bib0008","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbmt.2007.12.497","article-title":"Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies","volume":"14","author":"Chang","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.070_bib0009","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/bmt.2009.73","article-title":"Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors","volume":"44","author":"Zhao","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.070_bib0010","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/sj.leu.2404892","article-title":"Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia","volume":"21","author":"Savani","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2024.01.070_bib0011","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1182\/bloodadvances.2017008631","article-title":"The number of CD56dim NK cells in the graft has a major impact on risk of disease relapse following allo-HSCT","volume":"1","author":"Maggs","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2024.01.070_bib0012","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41409-021-01232-x","article-title":"Safety and efficacy of the low-dose memory (CD45RA-depleted) donor lymphocyte infusion in recipients of \u03b1\u03b2 T cell-depleted haploidentical grafts: results of a prospective randomized trial in high-risk childhood leukemia","volume":"56","author":"Dunaikina","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.070_bib0013","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41409-017-0035-y","article-title":"Low-dose donor memory T-cell infusion after TCR alpha\/beta depleted unrelated and haploidentical transplantation: results of a pilot trial","volume":"53","author":"Maschan","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.070_bib0014","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/vox.13266","article-title":"Efficacy and safety of a reduced dose of plerixafor in combination with granulocyte colony-stimulating factor in healthy haploidentical stem cell donors","volume":"117","author":"Kurnikova","year":"2022","journal-title":"Vox Sang"},{"key":"10.1016\/j.jtct.2024.01.070_bib0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jca.21891","article-title":"Plerixafor added to G-CSF allows mobilization of a sufficient number of hematopoietic progenitors without impacting the efficacy of TCR -alpha\/beta depletion in pediatric haploidentical and genoidentical donors failing to mobilize with G-CSF alone","volume":"36","author":"Kurnikova","year":"2021","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.jtct.2024.01.070_bib0016","doi-asserted-by":"crossref","first-page":"64","DOI":"10.17650\/1818-8346-2016-11-4-64-73","article-title":"Standardization of flow cytometric minimal residual disease monitoring in children with B-cell precursor acute lymphoblastic leukemia. Russia\u2013Belarus multicenter group experience","volume":"11","author":"Popov","year":"2016","journal-title":"Oncohematology"},{"key":"10.1016\/j.jtct.2024.01.070_bib0017","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1007\/s00432-022-04378-3","article-title":"One-point flow cytometric MRD measurement to identify children with excellent outcome after intermediate-risk BCP-ALL: results of the ALL-MB 2008 study","volume":"149","author":"Popov","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jtct.2024.01.070_bib0018","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/biomet\/77.1.147","article-title":"Martingale-based residuals for survival models","volume":"77","author":"Therneau","year":"1990","journal-title":"Biometrika"},{"key":"10.1016\/j.jtct.2024.01.070_bib0019","doi-asserted-by":"crossref","first-page":"330.e1","DOI":"10.1016\/j.jtct.2021.01.010","article-title":"Serotherapy-free regimen improves non-relapse mortality and immune recovery among the recipients of \u03b1\u03b2 Tcell\u2013depleted haploidentical grafts: retrospective study in childhood leukemia","volume":"27","author":"Shelikhova","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2024.01.070_bib0020","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2352-3026(15)00045-9","article-title":"Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2024.01.070_bib0021","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1182\/blood-2016-06-721936","article-title":"Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation","volume":"128","author":"Admiraal","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.01.070_bib0022","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1182\/blood-2002-02-0350","article-title":"Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect","volume":"100","author":"Farag","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.01.070_bib0023","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.molimm.2004.07.037","article-title":"KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation","volume":"42","author":"Malmberg","year":"2005","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jtct.2024.01.070_bib0024","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbmt.2009.01.019","article-title":"Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses","volume":"15","author":"Gill","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.070_bib0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.beha.2016.10.010","article-title":"How important is NK alloreactivity and KIR in allogeneic transplantation?","volume":"29","author":"Shaffer","year":"2016","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jtct.2024.01.070_bib0026","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1182\/blood-2010-08-264085","article-title":"Killer Ig\u2013like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation","volume":"117","author":"Moretta","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.01.070_bib0027","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.smim.2014.02.004","article-title":"Natural killer cells in the treatment of high-risk acute leukaemia","volume":"26","author":"Locatelli","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jtct.2024.01.070_bib0028","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.it.2018.04.009","article-title":"NK Cells mediate a crucial graft-versus-leukemia effect in haploidentical-HSCT to cure high-risk acute leukemia","volume":"39","author":"Locatelli","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jtct.2024.01.070_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103206","article-title":"Dual effects of natural killer cells in transplantation for leukemia","volume":"158","author":"Arima","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jtct.2024.01.070_bib0030","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1182\/blood-2015-12-629055","article-title":"Exploitation of natural killer cells for the treatment of acute leukemia","volume":"127","author":"Handgretinger","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.01.070_bib0031","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.2011.08823.x","article-title":"Use of NK cell activity in cure by transplant: Review","volume":"155","author":"Leung","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2024.01.070_bib0032","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1073\/pnas.92.8.3536","article-title":"Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells","volume":"92","author":"Vitale","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtct.2024.01.070_bib0033","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1182\/blood-2008-06-164103","article-title":"Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity","volume":"113","author":"Pende","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.01.070_bib0034","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00281-008-0136-1","article-title":"Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation","volume":"30","author":"Velardi","year":"2008","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jtct.2024.01.070_bib0035","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbmt.2009.11.022","article-title":"Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation","volume":"16","author":"Symons","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.070_bib0036","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bbmt.2018.01.013","article-title":"Selecting the best donor for haploidentical transplant: impact of HLA, killer cell immunoglobulin-like receptor genotyping, and other clinical variables","volume":"24","author":"Solomon","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.070_bib0037","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2014-09-599993","article-title":"Haploidentical hematopoietic transplantation from KIR ligand\u2013mismatched donors with activating KIRs reduces nonrelapse mortality","volume":"125","author":"Mancusi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.01.070_bib0038","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/blood-2014-03-565069","article-title":"KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL","volume":"124","author":"Oevermann","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.01.070_bib0039","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00262-008-0601-7","article-title":"Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by natural killer cells","volume":"58","author":"Verheyden","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jtct.2024.01.070_bib0040","doi-asserted-by":"crossref","first-page":"601.e1","DOI":"10.1016\/j.jtct.2022.06.023","article-title":"Lineage-specific relapse prediction after haploidentical transplantation with post-transplant cyclophosphamide based on recipient HLA-B-leader genotype and HLA-C-group KIR ligand","volume":"28","author":"Solomon","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2024.01.070_bib0041","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41409-021-01259-0","article-title":"Natural killer cell alloreactivity in HLA-haploidentical hematopoietic transplantation: a study on behalf of the CTIWP of the EBMT","volume":"56","author":"Ruggeri","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.070_bib0042","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/bmt.2015.343","article-title":"TCR-alpha\/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia","volume":"51","author":"Maschan","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.070_bib0043","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41409-019-0531-3","article-title":"Outcome of \u03b1\u03b2 T cell-depleted transplantation in children with high-risk acute myeloid leukemia, grafted in remission","volume":"55","author":"Maschan","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.070_bib0044","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.bbmt.2019.01.023","article-title":"\u03b1\u03b2 T cell-depleted haploidentical hematopoietic stem cell transplantation without antithymocyte globulin in children with chemorefractory acute myelogenous leukemia","volume":"25","author":"Shelikhova","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.070_bib0045","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after \u03b1\u03b2 T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.01.070_bib0046","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00277-014-2084-2","article-title":"KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3\/CD19-depleted grafts","volume":"93","author":"Michaelis","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2024.01.070_bib0047","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/blood-2008-05-158253","article-title":"Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib","volume":"113","author":"Yong","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.01.070_bib0048","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/10428194.2012.708026","article-title":"Sensitizing primary acute lymphoblastic leukemia to natural killer cell recognition by induction of NKG2D ligands","volume":"54","author":"Jardine","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2024.01.070_bib0049","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcyt.2020.09.010","article-title":"Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemia","volume":"23","author":"Story","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jtct.2024.01.070_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.638841","article-title":"Interaction between MDSC and NK cells in solid and hematological malignancies: impact on HSCT","volume":"12","author":"Tumino","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2024.01.070_bib0051","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41375-019-0585-7","article-title":"PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation","volume":"34","author":"Tumino","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2024.01.070_bib0052","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/1753425918820427","article-title":"Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin","volume":"25","author":"Suk Lee","year":"2019","journal-title":"Innate Immun"},{"key":"10.1016\/j.jtct.2024.01.070_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1202950","article-title":"Beyond \u03b1\u03b2 T cells: NK, iNKT, and \u03b3\u03b4T cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML","volume":"14","author":"Kent","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2024.01.070_bib0054","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3324\/haematol.2015.128439","article-title":"Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: results of the randomized AZABACHE Spanish trial","volume":"100","author":"Garc\u00eda-Sanz","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2024.01.070_bib0055","article-title":"Zoledronic acid boosts \u03b3\u03b4 T-cell activity in children receiving \u03b1\u03b2+ T and CD19+ cell-depleted grafts from an HLA-haplo-identical donor","volume":"6","author":"Bertaina","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jtct.2024.01.070_bib0056","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3389\/fimmu.2020.00699","article-title":"Immune modulation properties of zoledronic acid on TcR\u03b3\u03b4 T-lymphocytes after TcR\u03b1\u03b2\/CD19-depleted haploidentical stem cell transplantation: an analysis on 46 pediatric patients affected by acute leukemia","volume":"11","author":"Merli","year":"2020","journal-title":"Front Immunol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724001647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724001647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:02:03Z","timestamp":1762639323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724001647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2666636724001647"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.01.070","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with \u03b1\u03b2 T Cell Depletion in a Pediatric Cohort","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.01.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}